Literature DB >> 21497307

Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.

Paul Valensi1, Luc Lorgis, Yves Cottin.   

Abstract

The prevalence, incidence, risk factors and prognosis of silent myocardial infarction are less well known than those of silent myocardial ischaemia. The aims of this article are to evaluate the prevalence and incidence of silent myocardial infarction in subjects with or without a history of cardiovascular disease and in diabetic patients, and to identify potential risk factors and estimate prognosis through a review of the literature. A Medline search identified studies that provided data on the prevalence, incidence, potential risk factors and/or prognosis of silent myocardial infarction, among cohorts from the general population and large clinical studies of at-risk patients (with hypertension or a history of cardiovascular disease or diabetes). The search identified 15 studies in subjects from the general population, five in hypertensive patients, six in patients with a history of cardiovascular disease, and 10 in diabetic patients. The prevalence and incidence of silent myocardial infarction appear highly variable depending on the population studied, the patients' ages, and the method used to detect silent myocardial infarction. In the general population, the prevalence of silent myocardial infarction increased markedly with increasing age (up to>5% in elderly subjects). Hypertension causes only a moderate increase in prevalence, whereas underlying cardiovascular diseases and diabetes are associated with marked increases in prevalence. The incidence of silent myocardial infarction changes in the same way. The main predictive factors of silent myocardial infarction are hypertension, history of cardiovascular diseases and diabetes duration. Silent myocardial infarction is associated with as poor a prognosis as clinical myocardial infarction. The frequency of silent myocardial infarction and the poor prognosis in at-risk patients amply justify its systematic early detection and active management.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21497307     DOI: 10.1016/j.acvd.2010.11.013

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  33 in total

1.  Looking after silent coronary artery disease in diabetic patients. When and how?

Authors:  Paul Valensi
Journal:  Endocrine       Date:  2011-10       Impact factor: 3.633

2.  Electrocardiographic abnormalities and mortality in aging survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study.

Authors:  Daniel A Mulrooney; Elsayed Z Soliman; Matthew J Ehrhardt; Lu Lu; Daniel A Duprez; Russell V Luepker; Gregory T Armstrong; Vijaya M Joshi; Daniel M Green; Deokumar Srivastava; Matthew J Krasin; G Stephen Morris; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Am Heart J       Date:  2017-04-04       Impact factor: 4.749

3.  Kidney Stone History and Adverse Outcomes After Percutaneous Coronary Intervention.

Authors:  Chao-Han Lai; Li-Ching Huang; S Neil Holby; Ying-Ju Lai; Pei-Fang Su; Yu-Sheng Cheng; Yu Shyr; Ryan S Hsi
Journal:  Urology       Date:  2019-11-04       Impact factor: 2.649

4.  Synergistic impacts of Montelukast and Klotho against doxorubicin-induced cardiac toxicity in Rats.

Authors:  Heba A Elnoury; Salwa A Elgendy; Samar H Baloza; Heba I Ghamry; Mohamed Soliman; Eman Abdel-Mohsen Abdel-Aziz
Journal:  Toxicol Res (Camb)       Date:  2022-06-20       Impact factor: 2.680

5.  Silent Myocardial Infarction and Acute Multiorgan Failure in a COVID-19 Patient: A Case Report.

Authors:  Nischit Baral; Andrea Montalbano; Ashiya Khan; Mehak Qureshi; Pankaj Luitel
Journal:  JNMA J Nepal Med Assoc       Date:  2021-10-15       Impact factor: 0.556

6.  Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort.

Authors:  Richard Brandon Stacey; Janice Zgibor; Paul E Leaverton; Douglas D Schocken; Jennifer A Peregoy; Mary F Lyles; Alain G Bertoni; Gregory L Burke
Journal:  J Am Geriatr Soc       Date:  2018-10-09       Impact factor: 5.562

7.  ST-segment elevation myocardial infarction with non-chest pain presentation at the Emergency Department: Insights from the Singapore Myocardial Infarction Registry.

Authors:  Jeremy Zhenwen Pong; Andrew Fu Wah Ho; Timothy Xin Zhong Tan; Huili Zheng; Pin Pin Pek; Ching-Hui Sia; Derek John Hausenloy; Marcus Eng Hock Ong
Journal:  Intern Emerg Med       Date:  2019-06-05       Impact factor: 3.397

8.  Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes.

Authors:  Mélanie Gaudillière; Charlotte Marsot; Laetitia Balaire; Laure Groisne; Myriam Moret; Sylvie Villar-Fimbel; Philippe Douek; Philippe Moulin; Sybil Charrière
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

9.  Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study.

Authors:  D S Prasad; Zubair Kabir; K Revathi Devi; A K Dash; B C Das
Journal:  Open Heart       Date:  2014-06-11

10.  Do diabetic patients with acute coronary syndromes have a higher threshold for ischemic pain?

Authors:  José Carlos Nicolau; Carlos José Dornas Gonçalves Barbosa; André Franci; Luciano Moreira Baracioli; Marcelo Franken; Felipe Gallego Lima; Roberto Rocha Giraldez; Roberto Kalil Filho; José Antônio Franchini Ramires; Robert P Giugliano
Journal:  Arq Bras Cardiol       Date:  2014-07-29       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.